LAUREL LOVELL: Open Payments
NPI 1700668753 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,086 in 96 payments from 27 companies in 2025. Trend: 2023 $36 · 2024 $1,694 · 2025 $2,086
Food & beverage: $2,069Travel & lodging: $17
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $239 |
| UCB, Inc. | 7 | $199 |
| Eisai Inc. | 6 | $190 |
| JAZZ PHARMACEUTICALS INC. | 7 | $179 |
| Axsome Therapeutics, Inc. | 8 | $152 |
| Lundbeck LLC | 9 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| Alexion Pharmaceuticals, Inc. | 4 | $98 |
| Genentech USA, Inc. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 6 | $90 |
Products named: QULIPTA, Leqembi, KESIMPTA, EPIDIOLEX, ULTOMIRIS, Ocrevus Zunovo, Symbravo, REXULTI.
Industry payments across FL — which companies pay providers there.
